These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18794527)

  • 1. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins.
    Ruby MA; Nomura DK; Hudak CS; Mangravite LM; Chiu S; Casida JE; Krauss RM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14561-6. PubMed ID: 18794527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes.
    Ruby MA; Nomura DK; Hudak CS; Barber A; Casida JE; Krauss RM
    PLoS One; 2011; 6(11):e26415. PubMed ID: 22073164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
    Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
    Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
    Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.
    Jiang LS; Pu J; Han ZH; Hu LH; He B
    Cardiovasc Res; 2009 Mar; 81(4):805-13. PubMed ID: 19074161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
    Bartelt A; Orlando P; Mele C; Ligresti A; Toedter K; Scheja L; Heeren J; Di Marzo V
    Diabetologia; 2011 Nov; 54(11):2900-10. PubMed ID: 21847582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
    Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H
    J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
    Dichek HL; Brecht W; Fan J; Ji ZS; McCormick SP; Akeefe H; Conzo L; Sanan DA; Weisgraber KH; Young SG; Taylor JM; Mahley RW
    J Biol Chem; 1998 Jan; 273(4):1896-903. PubMed ID: 9442022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.
    Pisanti S; Picardi P; Pallottini V; Martini C; Petrosino S; Proto MC; Vitale M; Laezza C; Gazzerro P; Di Marzo V; Bifulco M
    J Cell Physiol; 2015 Dec; 230(12):2905-14. PubMed ID: 25684344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.
    Hill MN; Ho WS; Meier SE; Gorzalka BB; Hillard CJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):99-102. PubMed ID: 16324692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion.
    Kypreos KE; van Dijk KW; van Der Zee A; Havekes LM; Zannis VI
    J Biol Chem; 2001 Jun; 276(23):19778-86. PubMed ID: 11279066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tambyrajah L; Pronk ACM; Blomberg N; Giera M; Wang Y; Coskun T; van der Stelt M; Rensen PCN; Kooijman S
    J Lipid Res; 2021; 62():100070. PubMed ID: 33766515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.